safingol and Hepatitis C, Chronic

safingol has been researched along with Hepatitis C, Chronic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Dietz, J; Grammatikos, G; Herrmann, E; Jakobi, K; Pfeilschifter, J; Röhrig, AM; Sarrazin, C; Thomas, D; Welsch, C; Zeuzem, S	1

Other Studies

1 other study(ies) available for safingol and Hepatitis C, Chronic

Article	Year
The role of serum sphingolipids as potential biomarkers of non-response to direct acting antiviral therapy in chronic hepatitis C virus infection. Journal of viral hepatitis, 2023, Volume: 30, Issue:2 Topics: Antiviral Agents; Biomarkers; Chromatography, Liquid; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Humans; Retrospective Studies; Sphingolipids; Sphingosine; Sustained Virologic Response; Tandem Mass Spectrometry	2023

Article

Year

The role of serum sphingolipids as potential biomarkers of non-response to direct acting antiviral therapy in chronic hepatitis C virus infection.

Journal of viral hepatitis, 2023, Volume: 30, Issue:2

Topics: Antiviral Agents; Biomarkers; Chromatography, Liquid; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Humans; Retrospective Studies; Sphingolipids; Sphingosine; Sustained Virologic Response; Tandem Mass Spectrometry

2023